In 1922 Alexander Fleming reported on a 'remarkable bacteriolytic' element found in tissues and secretions, and coined the name 'Iysozyme' for this activity. It was subsequently established that lysozyme acts through the dissolution of N-acetylglucosaminyl-N-acetylmuramic acid linkages in the cell walls of susceptible microorganisms, and the synonym 'muramidase' is now widely used. The enzyme is present in easily detectable amounts in human milk, tears, saliva, and serum. Moderately elevated serum levels have been reported in cases of tuberculosis, sarcoidosis, and myeloproliferative diseases (Finch, Lamphere, and Jablon, 1964; Osserman and Lawlor, 1966; Catovsky, Galton, and Griffin, 1971) while relatively enormous increases in serum and urine values are found in cases of leukaemia in which the malignant clone shows monocytic differentiation (Osserman and Lawlor, 1966) . Serum muramidase in normal subjects and in patients with myeloproliferative disorders is thought to represent enzyme liberated from dying polymorphonuclear leucocytes (Fink and Finch, 1968) , while the elevated levels in granulomatous diseases and in leukaemia appear to reflect liberation from, respectively, tissue histiocytes and from myelomonocytic cells (Catovsky et al, 1971) . Muramidase in tears, saliva, and other secretions probably represents synthesis by glandular cells.
Attempts to localize the cellular origins of human muramidase have been hampered by the lack of a Received for publication 16 October 1974. simple and accurate histological technique for detecting the enzyme. Methods hitherto described have either exploited the saccharolytic properties of the enzyme, using Micrococcus lysodeikticus or chitin as a substrate, or have relied on the use of labelled antibodies. Neither of these approaches has allowed full examination of muramidase distribution in human tissues (table I). The former methods suffer from the disadvantage that the muramidase must still be enzymatically active when the tissue is tested, ie, tissue must be fresh and unfixed. Immunological techniques, on the other hand, whilst not requiring the preservation of enzyme activity, are also considered incompatible with formalin fixation. Thus Asamer, Schmalzl, and Braunsteiner (1971) used alcohol-fixed blood and bone marrow smears, while Erlandsen and Parson (1973) and Stemberger, Hardy, Cuculis, and Meyer (1970a) examined respectively glutaraldehyde-and osmiumfixed tissues. Immunofluorescent techniques have the additional disadvantage of poor tissue and cellular morphology, particularly in comparison with the excellent histological results which can be achieved by immunoperoxidase methods Burns, Hambridge, and Taylor, 1974; Taylor and Mason, 1974) .
The present report describes the use of immunohistological techniques for specifically staining human muramidase. These methods utilize peroxidase-conjugated antibodies, or immune complexes of peroxidase with rabbit antibody to peroxidase (PAP), and are applicable to all formalin-fixed. Galton (1973) Lysis of micrococcus Myeloid leukaemic blast cells Erlandsen and Parson (1973) Immunoperoxidase Paneth cells in small intestine Diamino-benzidine (DAB3) reaction, counterstain with haematoxylin, dehydrate, mount in DPX Table III The PAP (peroxidase-anti-peroxidase immune complex) method' 'All reactions in Tris buffer (pH 7-6), all washes after stages 2, 3, 4, 5, and 6 in Tris saline. 2Stage 3 optional. 3DAB 3 3' diamino-benzidine tetrahydrochloride (BDH Chemicals, Poole, England) 6 mg in 10 ml of Tris buffer containing freshly added hydrogen peroxide 0-01 ,'.
smears were allowed to dry after ethanol fixation and subsequently treated in the same way as tissue sections. All slides were transferred to absolute methanol containing 0 3 % hydrogen peroxide in order to block the endogenous peroxidase activity (of granulocytes and red cells) which interferes with the interpretation of results (see Burns et al, 1974) . The subsequent method is summarized in tables II and II.
All tissues were initially examined by the 'peroxidase conjugate' method (table II and Taylor . Those tissues in which results were equivocal were subsequently re-examined by the more sensitive PAP method (table III and Taylor, 1974 
Granulation tissue
In granulation tissue from the base of a peptic ulcer the majority of cells (including histiocytes and fibroblasts) were negative. In areas where acute inflammatory cells were present, a few histiocytes showed granular positivity.
Fat necrosis
A minority of the giant cells found in association with cholesterol clefts were faintly positive.
Lipid-containingphagocytes A proportion of Gaucher's histiocytes, and a few giant cells in one of the two xanthomata examined stained weakly and diffusely for muramidase. In the latter instance the positive reaction for muramidase was associated with other features of chronic irritation, possibly the result of minor trauma.
Eosinophilicgranuloma
The eosinophil polymorphs which are a striking feature of this condition showed strong granular positivity. In addition scattered foamy histiocytes contained moderate amounts of the enzyme. The majority of other histiocytic cells, which tended to be smaller, were negative or very weakly positive.
SPECIFICITY OF MURAMIDASE STAIN
The antimuramidase antiserum was diluted 1/20 in a 1 0 mg/ml solution of purified muramidase (MX 2), and applied to several sections in which muramidasepositive cells appeared to be numerous. In each case the positive staining was completely abolished, confirming the specificity of the reaction for muramidase.
Discussion
The present investigation confirms most of the previously reported work on the cellular distribution of human muramidase, in that normal myeloid and monocytic cells contained the enzyme. A single discrepancy lies in the fact that we found strong muramidase activity in mature eosinophils in tissue sections but not in blood films. This possibly reflects differences in the methods of processing for sections and smears. Three other reports have suggested that there is little or no enzyme in eosinophils in smears (Scholnik and Kass, 1973; Briggs, Perillie, and Finch, 1966; Syren and Raeste, 1971) .
Studies of human muramidase (quoted in table I) have been supplemented by investigations of muramidase activity in animal tissues, and the present survey may be considered in relation to this work. Because of the species antigenic specificity of muramidase, we have not been able to apply the immunoperoxidase technique to tissue of non-human origin.
RENAL TUBULAR CELLS
The enzyme has been demonstrated in rat and mouse proximal tubular cells (Glynn and Parkmann, 1964; Klockars and Osserman, 1974) , a finding which was confirmed for man in the present study. The kidney is known to excrete muramidase readily into the glomerular filtrate, whence it is reabsorbed and catabolized by proximal tubular cells (Balazs and Roepke, 1966) .
LACRIMAL GLAND Fleming, in his original paper on muramidase, described powerful activity in human tears, and our present findings demonstrate that the majority of the secretory cells of the lacrimal gland are capable of muramidase synthesis. Scholnik and Kass (1973) had previously found muramidase activity in rabbit lacrimal glands. However, Klockars and Osserman (1974) discovered an apparent species difference in that rat lacrimal tissue was devoid of this enzyme.
CARTILAGE
Muramidase has been detected in chick and human rat cartilage (Kuettner, Eisenstein, Soble, and Arsenis, 1971; Greenwald and Sajdera, 1971; Greenwald, Josephson, Diamond, and Tang, 1972) . In all these studies muramidase was found to be extracellular. Kuettner et al (1971) of Greenwald et al (1972) and of Eisenstein, Arsenis, and Kuettner (1970) Klockars and Osserman (1974) on rat small intestine, and by Ghoos and Vantrappen (1971) on mouse jejunum. The function of Paneth cells is unknown. Klockars and Osserman (1974) cite the large number of Paneth cells in the small intestine of the Brazilian ant-bear as evidence that they were originally evolved for the secretion of chitin-dissolving mura- midase. An The distribution of muramidase (lysozyme) in human tissues was no suggestion of positivity using the more sensitive PAP method in which non-specific staining is greatly reduced.
MACROPHAGES AND HlSTIOCYTES
It was apparent in this study that many histiocytes whether in hepatic, pulmonary, or lymphatic tissues, were negative for muramidase. These negative cells included such declared phagocytes as pulmonary 'heart failure' alveolar macrophages and carboncontaining histiocytes.
Those histiocytes or macrophages which were found to contain the enzyme fell into three categories: Klockars and Osserman (1974) who reported negative staining in all the rat lymph nodes which they examined with the exception of a single paraaortic node in which germinal centre hyperplasia and sinus histiocytosis were associated with the presence of many muramidase-positive histiocytes. There is further evidence for the hypothesis that muramidase is synthesized only by 'activated' histiocytes in the increased serum levels found in tuberculosis and sarcoidosis (Finch et al, 1964; Osserman and Lawlor, 1966) and also in the work of Cappucino, Winston, and Perri (1964) and of Glynn (1968) who demonstrated an increase in splenic muramidase in mice receiving BCG injections.
Conclusion
The technique described here may be of value in the study of the monocyte/histiocyte series in health 3* and in disease. Possible clinical applications include the investigation of monocytic and myelomonocytic leukaemias, particularly when the latter appears as a terminal event in cases of multiple myeloma (Andersen and Videbaek, 1970) .
